Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. - Test2 - elhamkhani - TriplyDB

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

http://www.wikidata.org/entity/Q35536118

about

The life and times of the Enterococcus Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses Vancomycin-resistant enterococci.Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusion.Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus Current perspectives on glycopeptide resistance.Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC Continuous infusion of beta-lactam antibiotics Single-dose antibiotic therapy: what has the past taught us?Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats.Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens.Virulence of enterococci.The rise of the Enterococcus: beyond vancomycin resistance.Screening and treatment of infections caused by resistant enterococci.Mechanisms of resistance of enterococci to beta-lactam antibiotics.Therapy of enterococcal infections.Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.Beta-lactam antibiotics: is continuous infusion the preferred method of administration?Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia.Enterococcus, an emerging pathogen.

P2860

Q24616875-5C0C9BA3-B181-4B8E-AD12-B5700BA10FD4 Q24675002-2EE5F603-D6A6-4046-9EAC-D838E0DA17D5 Q28361126-227347D8-C850-4AE3-B7E4-3E99B8672FE9 Q33748818-7DFF2970-DB14-449A-8CEE-E3F0F4B32CB3 Q33975592-AE3DE8F9-3E36-43F5-88C9-8AAA1E70A33F Q35013772-D42D1C7E-547F-4DF5-AEC4-8BA78C09A105 Q35121434-B32D8BF0-ACE9-4078-9C3A-5973EC05A736 Q35123123-D5245644-BEF5-440D-9AE7-DAA39ADBC6B7 Q35136019-8C97237F-13AA-40A9-ADC0-8AE5DCC70FCB Q35136449-3255F746-4244-4CE6-AAAA-E4836D8D4E4F Q35253384-64FEC93B-E5BA-4963-AD2A-84852AC06C03 Q35368590-93CBA8B5-7A9C-4267-A368-E616B97FCF7B Q35534742-D1B801C4-4171-43E0-A9C7-C66B3E957E18 Q35637864-90751DE0-EAFC-4EA8-A688-2E3679FBE115 Q35656806-AB3CED22-09EC-41DB-B180-D92A54F76063 Q35661686-A305373A-4417-4F67-8C47-485EA3B0DB1C Q35816904-32A6773B-0621-4703-8F26-BFC83A0D4FBD Q35819639-2532AFE1-4997-4D63-8843-66630308CE79 Q35823261-515E454C-F6ED-4A79-B507-24460D8877CA Q35843281-0E4AAC68-8DFB-4242-8581-7C5350A09460 Q36641988-78412F2D-02A0-4E1C-88E2-680D6CE9B8CB Q36752156-009A060D-DC53-42E2-999E-C0E611C84BB2 Q37711795-FFF2D989-9C1B-499F-A013-5FCD4843EB3F Q37909566-4F532707-9C4E-46DA-9B19-7124B7A24D36 Q37909576-738959ED-D27F-4F61-8877-79F3354D5E5C Q39470313-614C6E51-9AFD-4BCB-B12E-47A78856599A Q39472331-45248DC9-2574-4E82-B215-FBC9399DF358 Q39475317-8EA1B8F6-9CDD-4400-BBE1-7E0C557C3763 Q39475968-5D609123-9851-4A1A-BCC8-4A7847369BA4 Q39746366-703896D2-7693-4952-9870-A7A28886B460 Q39815914-EC3E35EB-A34F-4868-B3DF-9C242211E1C7 Q39816575-18A654CA-5774-4BD1-90D1-BEA45FE1A3CB Q39816811-D3BCF152-9E82-4C05-98BD-A8DB133D5D23 Q39833014-3E743512-E4F2-43B0-83F2-5653086BB45C Q39865205-77E097CD-4451-4BF2-AD81-2B2C5BA2BE60 Q39874965-735DD92A-3E7E-4076-B295-EF3E59C06838 Q40284385-A47ADBB3-BC37-4A07-AE77-D03080D3D70E Q40459002-2EBE9496-7E98-49A6-B50D-502B47E7C576 Q40688395-1FE743DA-BAE6-4FF6-A82E-6273031F804B Q40785841-B7110E1C-6263-41FC-A688-0F63A6F1C1DC

P2860

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

http://www.wikidata.org/entity/Q35536118

description

1987 nî lūn-bûn

@nan

1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

@ast

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

@en

type

label

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

@ast

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

@en

prefLabel

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

@ast

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

@en

P1433

Q35536118-0EC6D393-8179-4B9A-A5BD-EC027E607BCB

P1476

Q35536118-931A3426-67CC-42E3-847E-4FC5F080D08B

P2093

Q35536118-2D94854F-963E-49D2-8455-A5CBF7BEDE00

Q35536118-34B3A2B4-7A55-4715-9F10-08526AF2D6DC

Q35536118-3F3CAF03-9572-42EC-AAA7-2ECF7A88E094

Q35536118-88C23FB4-F758-496B-A2E7-2A542445AFCD

Q35536118-CE80EA6D-5F40-4246-B982-663D26AC0C6C

P2860

Q35536118-13E64C57-5DBC-4A48-AD69-BA1B53A05DD5

Q35536118-210B99E1-B376-4E98-A9C6-0171F933E5AE

Q35536118-48D76F46-A554-4EFD-82D6-BE9E070953D9

Q35536118-50EF5F70-7274-44CD-B5D8-7325D3C592DE

Q35536118-5260B68F-2002-4AD0-B0F4-E69570B0A24E

Q35536118-9158D865-BDF4-47D4-8BC9-A15E34961438

Q35536118-A70239E2-A977-4FF3-BD24-E0D40220A038

Q35536118-BC1340F6-42DC-41B9-B250-FCA6F0BCA7EA

Q35536118-C5179D02-6256-448D-B371-80EAC3648D84

Q35536118-E33BC502-93CB-40DE-BCD9-4BB4FE6D7A0E

P304

Q35536118-EA392FB2-2B32-4833-92B2-8D26D8FB5769

P31

Q35536118-4E06A8DE-6420-42DC-8EB1-882309925DDA

P356

Q35536118-82D34AE6-7F49-47D8-88F9-7EF5DD8BE4EA

P407

Q35536118-41EDA0EA-C4B6-4AC5-BF17-433971C542F7

P433

Q35536118-87FEA7DF-9EB9-46F0-9FEB-082A4E4BCFED

P478

Q35536118-E8E8D7E5-3FDE-435A-86CC-3169BEC97D61

P577

Q35536118-9BDB025F-2A5D-4BEF-B5D1-EC50C37A8B3B

P698

Q35536118-CEA793F4-8EC9-4593-88C7-12CE8AC19DE9

P932

Q35536118-94B756EE-E990-43D9-AAC1-D8881DB24A48

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

@en

P2093

Eliopoulos GM

http://www.w3.org/2001/XMLSchema#string

Moellering RC Jr

http://www.w3.org/2001/XMLSchema#string

Thauvin C

http://www.w3.org/2001/XMLSchema#string

Wennersten C

http://www.w3.org/2001/XMLSchema#string

Willey S

http://www.w3.org/2001/XMLSchema#string

P2860

Bacterial endocarditis. A review of 148 cases.

Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae.

Intrarenal concentrations of ampicillin in acute pyelonephritis.

Ampicillin therapy of experimental enterococcal endocarditis.

Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo.

Rat model of experimental endocarditis

Synergism of ampicillin and gentamicin against obstructive pyelonephritis due to Escherichia coli in rats.

Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases.

Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.

Statistics in practice. Comparing the means of several groups.

P304

139-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.31.2.139

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1987-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3105445

http://www.w3.org/2001/XMLSchema#string

P932

174678

http://www.w3.org/2001/XMLSchema#string